These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 29926512)

  • 1. Potentially effective method for fetal gender determination by noninvasive prenatal testing for X-linked disease.
    Noda Y; Kato T; Kato A; Nishizawa H; Miyazaki J; Ito M; Terasawa S; Sekiya T; Fujii T; Kurahashi H
    Congenit Anom (Kyoto); 2019 May; 59(3):88-92. PubMed ID: 29926512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early non-invasive detection of fetal Y chromosome sequences in maternal plasma using multiplex PCR.
    Kolialexi A; Tounta G; Apostolou P; Vrettou C; Papantoniou N; Kanavakis E; Antsaklis A; Mavrou A
    Eur J Obstet Gynecol Reprod Biol; 2012 Mar; 161(1):34-7. PubMed ID: 22261468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Combining Effects of Cell-Free Circulating Tumor DNA of Breast Tumor to the Noninvasive Prenatal Testing Results: A Simulating Investigation.
    Cai YH; Yao GY; Chen LJ; Gan HY; Ye CS; Yang XX
    DNA Cell Biol; 2018 Jul; 37(7):626-633. PubMed ID: 29957029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Noninvasive prenatal screen of trisomy-21 using maternal plasma fetal free RNA allelic ratio].
    Xu Y; Zhai S; Luo X; Zhang Y; Ran L; Ren L
    Zhonghua Fu Chan Ke Za Zhi; 2015 Aug; 50(8):568-75. PubMed ID: 26675178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of fetal unmodified and 5-hydroxymethylated CG sites in maternal cell-free DNA for non-invasive prenatal testing.
    Gordevičius J; Narmontė M; Gibas P; Kvederavičiūtė K; Tomkutė V; Paluoja P; Krjutškov K; Salumets A; Kriukienė E
    Clin Epigenetics; 2020 Oct; 12(1):153. PubMed ID: 33081811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contingent first-trimester screening for aneuploidies with cell-free DNA in a Danish clinical setting.
    Miltoft CB; Rode L; Ekelund CK; Sundberg K; Kjaergaard S; Zingenberg H; Tabor A
    Ultrasound Obstet Gynecol; 2018 Apr; 51(4):470-479. PubMed ID: 28640470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive Prenatal Diagnosis of Single-Gene Disorders by Use of Droplet Digital PCR.
    Camunas-Soler J; Lee H; Hudgins L; Hintz SR; Blumenfeld YJ; El-Sayed YY; Quake SR
    Clin Chem; 2018 Feb; 64(2):336-345. PubMed ID: 29097507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive view and increased likely uptake of follow-up testing with analysis of cell-free fetal DNA as alternative to invasive testing among Danish pregnant women.
    Miltoft CB; Rode L; Tabor A
    Acta Obstet Gynecol Scand; 2018 May; 97(5):577-586. PubMed ID: 29350746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for trisomies by cell-free DNA testing of maternal blood: consequences of a failed result.
    Revello R; Sarno L; Ispas A; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Jun; 47(6):698-704. PubMed ID: 26743020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enrichment of fetal and maternal long cell-free DNA fragments from maternal plasma following DNA repair.
    Vong JSL; Jiang P; Cheng SH; Lee WS; Tsang JCH; Leung TY; Chan KCA; Chiu RWK; Lo YMD
    Prenat Diagn; 2019 Jan; 39(2):88-99. PubMed ID: 30575063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical application of noninvasive prenatal diagnosis using cell free fetal DNA in maternal plasma].
    Hou QF; Wu D; Chu Y; Kang B; Liao SX; Yang YL; Zhang CY; Zhang JX; Wu G
    Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):813-7. PubMed ID: 23302120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-free DNA analysis for noninvasive examination of trisomy.
    Norton ME; Jacobsson B; Swamy GK; Laurent LC; Ranzini AC; Brar H; Tomlinson MW; Pereira L; Spitz JL; Hollemon D; Cuckle H; Musci TJ; Wapner RJ
    N Engl J Med; 2015 Apr; 372(17):1589-97. PubMed ID: 25830321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Routine first-trimester screening for fetal trisomies in twin pregnancy: cell-free DNA test contingent on results from combined test.
    Galeva S; Konstantinidou L; Gil MM; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2019 Feb; 53(2):208-213. PubMed ID: 30353581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA sequencing versus standard prenatal aneuploidy screening.
    Bianchi DW; Parker RL; Wentworth J; Madankumar R; Saffer C; Das AF; Craig JA; Chudova DI; Devers PL; Jones KW; Oliver K; Rava RP; Sehnert AJ;
    N Engl J Med; 2014 Feb; 370(9):799-808. PubMed ID: 24571752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of cell-free DNA-based non-invasive prenatal testing in a National Health Service Regional Genetics Laboratory.
    Togneri FS; Kilby MD; Young E; Court S; Williams D; Griffiths MJ; Allen SK
    Genet Res (Camb); 2019 Dec; 101():e11. PubMed ID: 31813398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contingent cfDNA Screening Implementation: Increasing Diagnostic Accuracy and Reducing Invasive Testing - 6 Years' Results in a Single Center.
    Cubo AM; Huélamo M; Martín-Seisdedos MC; Hernández-Hernández E; Lapresa-Alcalde MV; Rodríguez-Martín MO; Doyague MJ; Sayagués JM
    Fetal Diagn Ther; 2022; 49(3):103-113. PubMed ID: 35259749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive predictive value estimates for cell-free noninvasive prenatal screening from data of a large referral genetic diagnostic laboratory.
    Petersen AK; Cheung SW; Smith JL; Bi W; Ward PA; Peacock S; Braxton A; Van Den Veyver IB; Breman AM
    Am J Obstet Gynecol; 2017 Dec; 217(6):691.e1-691.e6. PubMed ID: 29032050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness and reliability of cell free fetal DNA screening for main trisomies in case of atypical profile on first trimester maternal serum screening.
    Carrara J; Vivanti A; Jani JC; Demain A; Costa JM; Benachi A
    J Transl Med; 2019 Nov; 17(1):398. PubMed ID: 31779618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-free fetal DNA versus maternal serum screening for trisomy 21 in pregnant women with and without assisted reproduction technology: a prospective interventional study.
    Costa JM; Letourneau A; Favre R; Bidat L; Belaisch-Allart J; Jouannic JM; Quarello E; Senat MV; Broussin B; Tsatsaris V; Demain A; Kleinfinger P; Lohmann L; Agostini H; Bouyer J; Benachi A
    Genet Med; 2018 Nov; 20(11):1346-1353. PubMed ID: 29493578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A method for improving the accuracy of non-invasive prenatal screening by cell-free foetal DNA size selection.
    He QZ; Wu XJ; He QY; Xiang JJ; Zhang CH; Lu L; Wang T; Li H
    Br J Biomed Sci; 2018 Jul; 75(3):133-138. PubMed ID: 29968522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.